Journal of Oral Pathology & Medicine

Papers
(The H4-Index of Journal of Oral Pathology & Medicine is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
38
It was not possible to detect BRAF V600E mutation in circulating cell‐free DNA from patients with ameloblastoma: A diagnostic accuracy study37
Calibration improves the agreement in grading oral epithelial dysplasia—Findings from a National Workshop in Malaysia34
Global Research Trends on the Links Between the Oral Microbiome and Cancer From 2014 to 2024: A Visualization Analysis33
Impact of Information Provided in Remote Case Discussions on Oral Medicine Teleconsultants' Diagnostic Impression28
Is vitamin D receptor (VDR) polymorphism associated with head and neck cancer risk? A systematic review and meta‐analysis27
Prediction of Extranodal Extension in Oral Squamous Cell Carcinoma Using Demographic and Clinicopathological Variables—Evidence From a Multicentre Study27
The Function of Hsa_circ_0001862 Regulating miR ‐23a‐ IRF1 / PPP2R5E25
Evaluating Temporomandibular Disorder Severity: A Four‐Dimensional Model25
Mucosal Melanoma of Head and Neck: A Rare and Aggressive Disease—A Register‐Based Cohort Study23
21
The FUS / COL11A1 / ZEB1 Axis Contributes to th20
Differential OAT methylation correlates with cell infiltration in tumor microenvironment and overall survival postradiotherapy in oral squamous cell 19
GPRASP1 is a candidate anti‐oncogene and correlates with immune microenvironment and immunotherapeutic efficiency in head and neck cancer19
17
The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakia17
Correction to “Synergistic Effect of Honokiol and 5‐Fluorouracil on Apoptosis of Oral Squamous Cell Carcinoma Cells”16
Molecular Alterations in Osteosarcomas of the Oral and Maxillofacial Region: A Scoping Review16
Long‐term effectiveness of a novel intra‐oral electro‐stimulator for the treatment of dry mouth in patients with Sjogren's syndrome: A randomised sham‐controlled feasibility study (LEO16
0.11343002319336